# Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

> **NCT04459273** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 26 (actual)

## Conditions studied

- Bladder Carcinoma
- Cervical Carcinoma
- Cholangiocarcinoma
- Hematopoietic and Lymphoid Cell Neoplasm
- Hepatocellular Carcinoma
- Malignant Adrenal Gland Neoplasm
- Malignant Brain Neoplasm
- Malignant Pleural Neoplasm
- Malignant Skin Neoplasm
- Malignant Solid Neoplasm
- Malignant Testicular Neoplasm
- Malignant Thymus Neoplasm
- Neuroendocrine Neoplasm
- Thyroid Gland Carcinoma
- Urothelial Carcinoma
- Cancer of Unknown Primary Site

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Gallium Ga 68 FAPi-46
- **PROCEDURE:** Positron Emission Tomography
- **RADIATION:** 18F-FDG

## Key facts

- **NCT ID:** NCT04459273
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-08-27
- **Primary completion:** 2025-06-24
- **Final completion:** 2027-07-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04459273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04459273, "Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04459273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
